NEW YORK, Jan. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol:…
Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this…
Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report 2025-2035" has been added to…
All it took to derail a rally that had sent shares of pure-play quantum computing stocks soaring was a single…
Dividend stocks trading at discounted prices can make for great investments if youre willing to be patient. Thats because, assuming…
High-yield dividend stocks may not appeal to some investors. However, if youre among those investors looking for income, stocks that…
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von…
NEW YORK, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…
SAN DIEGO, Jan. 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…
The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to…
NEW ORLEANS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former…
Johnson & Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a…
Johnson & Johnson (NYSE:JNJ) has said its chemotherapy-free combination extended lung cancer patients’ lives compared to AstraZeneca PLC (LSE:AZN)’s...…
…
Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both have generally…
NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer are included in this Analyst Blog.…
2 January 2025
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…
Monopar stock skyrockets 384% in three months following a licensing deal with AstraZeneca for a late-stage Wilson Disease candidate.…
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY),…
AIM-quoted cancer treatments developer Hutchmed (China) Ltd (LON: HCM) is selling non-core 45% interest in Shanghai Hutchison Pharmaceuticals to GP…
SAN FRANCISCO, Jan. 01, 2025 (GLOBE NEWSWIRE) -- AstraZeneca, the Anglo-Swedish pharmaceutical giant, has seen its stock price…
NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…
This report seeks to deliver an in-depth analysis of the worldwide oncology pharmaceuticals (cancer medications) market. It includes a thorough…
Quantum computing represents the next frontier in computational power. Once developed, these systems could solve complex problems in drug development,…
AstraZeneca and Daiichi Sankyo voluntarily withdraw regulatory filing for Dato-DXd in nonsquamous non-small cell lung cancer in the European Union.…
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the…
DJ Astrazeneca/Daiichi Sankyo ziehen EU-Zulassungsantrag für Lungenkrebsmittel zurück Von Najat Kantouar Dow Jones--Die Pharmakonzerne AstraZeneca und Daiichi Sankyo ziehen ihren…
AstraZeneca PLC (LSE:AZN) has pulled a marketing authorisation application for its key lung cancer drug in the European Union. FTSE…
24 December 2024
Datopotamab deruxtecan application in the EU for patients with advanced
nonsquamous non-small cell lung cancer voluntarily withdrawn
AstraZeneca and Daiichi Sankyo…
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…
AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong…
AMSTERDAM/LONDON (dpa-AFX) - Der britische Pharmakonzern Astrazeneca darf sein Lungenkrebsmedikament Tagrisso in der EU in einer weiteren Indikation verkaufen.…
AstraZeneca wins approval in the EU for the label expansion of Tagrisso to treat adult patients with locally advanced, unresectable…
U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were…
Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…
Beijing’s mayor called on AstraZeneca Plc to expand its research and development investment in the Chinese capital, signaling that a…
Astrazeneca (AZN) closed at $65.35 in the latest trading session, marking a +1.41% move from the prior day.…
DJ PRESSESPIEGEL/Unternehmen Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires. THYSSENKRUPP - Der Industriekonzern Thyssenkrupp hat eine…
AstraZeneca announces board refresh with new directors…
AstraZeneca names new non-executive directors…
Finding a company that can make you a millionaire from a modest investment is rare. However, they are out there…
Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business fundamentals. Three Motley Fool contributors…